By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TWi Pharmaceuticals, Inc. 

4F, No. 41, Lane 221
Kang Chien Rd.
Nei Hu Dist.  Taipei  114 
Phone: 886-2-26573350 Fax: 886-2-26573391


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014 8:58:31 AM
TWi Pharmaceuticals, Inc.i Announces ANDA Approval Of Generic Procardia Xl® Tablets 30 Mg, 60 Mg And 90 Mg In The United States 4/7/2014 9:28:15 AM
TWi Pharmaceuticals, Inc. Receives Patent Allowance for Its Reduced Food Effect Metformin Controlled Release Formulation in United States 7/16/2013 10:39:53 AM
TWi Pharmaceuticals, Inc.' Manufacturing Site for the Generic Version of Lidoderm(R) (Lidocane 5% patch) Passes US FDA cGMP Audit and Pre-Approval Inspection 5/29/2013 10:05:00 AM
TWi Pharmaceuticals, Inc. Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets 5/14/2013 9:35:08 AM
Shire plc Settles All Pending Litigation With Anchen Pharmaceuticals(USA), Inc. and TWi Pharmaceuticals, Inc. Concerning INTUNIV® 9/6/2012 11:03:35 AM
TWi Pharmaceuticals, Inc. Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients With Type 2 Diabetes 8/6/2012 10:44:03 AM
Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes, TWi Pharmaceuticals, Inc. Study 6/14/2011 6:23:26 AM
//-->